Psound Bytes Pro

Hear rheumatologist Dr. Lihi Eder from the University of Toronto discuss diagnostic biomarkers and the use of imaging to diagnose psoriatic arthritis. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from AbbVie and Novartis.

Hear Dr. Ron Prussick, from the Washington Dermatology Center, discuss the importance of diet in patients living with psoriasis. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from AbbVie and Novartis.

Can accountability and gamification improve treatment adherence? Hear Dr. Steven Feldman, Professor at Wake Forest University School of Medicine, discuss this and more. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from AbbVie and Novartis.

Patients living with psoriasis may have an increased risk of certain infections, but also certain infections can trigger or exacerbate psoriasis symptoms. Listen to dermatologist, Dr. Seth Forman, and his patient Katie Chambers as they discuss the intersection of infection and PsO. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from AbbVie and Novartis.

Although rare, erythrodermic psoriasis can be life-threatening. Listen to Dr. Mio Nakamura, Assistant Professor of Dermatology at the University of Michigan discusses this severe variant of psoriasis vulgaris. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from AbbVie and Novartis.

Hear Dr. Mona Shahriari, M.D., Assistant Clinical Professor of Dermatology at Yale University School of Medicine, the Associate Director of Clinical Trials at CCD Research and a senior editor for the Journal of Psoriasis and Psoriatic Arthritis, discuss discuss diagnosis and managing psoriasis in people with skin of color. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from AbbVie and Novartis.

Hear Shawn Kwatra, M.D., Associate Professor, Department of Dermatology at Johns Hopkins University School of Medicine and Director of John Hopkins Itch Center, discuss pathogenesis of itch, histaminergic pathways, treatments and more. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HSS, or the U.S. government. This program is supported by educational grants from AbbVie and Novartis.

Hear Bridget Myers is a resident at UC Davis Dermatology and first-place winner of the abstract competition at the 2022 Annual Residents’ Meeting to discuss the complex relationship between sleep and the gut microbiome in psoriasis.

For volunteer appreciation month, hear Dr. Meyer Horn, Medical Director, Dermatology and Aesthetics in Chicago and Julia Hamel, NPF Midwest Regional Development Manager discuss the importance of patients and providers volunteering with the NPF. Dr. Horn also shares his strategies for success.

Hear Jason Harris, NPF's VP of Government Relations & Advocacy, discuss treatment access and barriers with Dr. Jason Hawkes from UC Davis and Dr. G. Michael Lewitt from Illinois Dermatology Institute. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Join us for another Psound Bytes™ CME Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we sit down with Dr. Larry Green from George Washington University to discuss recent research related to topical treatments and psoriasis. For credit and disclosures, please visit: https://www.eeds.com/em/5751 This program is supported by educational grants from Amgen, Novartis, Janssen, and Pfizer.

Hear Dr. Steve Feldman, M.D., Professor, Department of Dermatology at Wake Forest School of Medicine, continue the discussion on psoriatic disease research and the latest treatment updates. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.

Hear Dr. Steve Feldman, MD, Professor, Department of Dermatology at Wake Forest School of Medicine, discuss psoriatic disease research and treatment updates. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.

Hear Vanessa Cutler, M.D., Clinical Assistant Professor, Department of Psychiatry at NYU Grossman School of Medicine, discuss the impacts body dysmorphic disorder has on patients living with psoriatic disease. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from Amgen, Novartis, Pfizer and UCB.

Join us for another Psound Bytes™ CME Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we continue to discuss recent research related to CBD and psoriatic disease with Dr. Adam Friedman from George Washington University and Dr. Jason Hawkes from UC Davis Health. This program is supported by educational grants from Amgen, Novartis, Janssen, and Pfizer.

Join us for another Psound Bytes™ CME Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we discuss recent research related to CBD and psoriatic disease with Dr. Adam Friedman from George Washington University and Dr. Jason Hawkes from UC Davis Health. This program is supported by educational grants from Amgen, Novartis, Janssen, and Pfizer.

In the second of this 2- part series, Dr. David Rosmarin, M.D., MAS, assistant professor at Tufts University School of Medicine, continues to share insights into psoriasis for primary care providers. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.

Hear Dr. David Rosmarin, M.D., MAS, assistant professor at Tufts University School of Medicine, provide an overview of psoriasis for primary care providers. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.

Hear rheumatologist Dr. Atul Deodhar from OHSU in Portland, OR discuss how treatments for PsA and SpA should be used optimally in clinical practice while patients John Latella and Roz Tolliver share their disease experiences and how they manage treatment changes. This is the final CME episode in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA. This program is supported by an educational grant from Pfizer Inc.

Managing chronic pain and fatigue in patients with PsA and spondyloarthritis can be challenging for providers. Hear rheumatologists Dr. Philip Mease (Director, Rheumatology Research Swedish Medical Center/Providence St. Joseph Health) and Dr. Ernest Choy (Cardiff University School of Medicine), and patients Melissa Leeolou and Minionette "Mini" Wilson discuss causes, symptoms, risks and the latest in managing chronic pain and fatigue successfully. This is the second of three CME episodes in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA. This program is supported by an educational grant from Pfizer Inc.